Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

The company is one of the leading players in the interventional cardiology market with its coronary stent product offerings. Boston Scientific markets a broad portfolio of internally-developed and ...

The following is a summary of “Evaluation of Small Vessel Bifurcation Stenting Using the Double-Kissing Culotte and Culotte ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

At the same time, metal-free percutaneous coronary intervention (PCI) and Drug-Eluting Balloons (DEB) present new possibilities for treating complex lesions without leaving permanent stents behind.

Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...

You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...

We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty. We conducted a nationwide analysis from ...

For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent implantation does not yield greater minimal stent area or reduce the ...